//
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study
Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF
Mechanical circulatory support devices in advanced heart failure: 2020 and beyond
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Dilated cardiomyopathy: so many cardiomyopathies!